Evan N Cohen
Evan N Cohen
Research Instructor, The University of Texas MD Anderson Cancer Center
Verified email at mdanderson.org
Title
Cited by
Cited by
Year
Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia
A Ferrajoli, BN Lee, EJ Schlette, SM O'Brien, H Gao, S Wen, WG Wierda, ...
Blood, The Journal of the American Society of Hematology 111 (11), 5291-5297, 2008
4882008
Phase II study of Lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non–adenoid cystic carcinoma …
M Agulnik, EWE Cohen, RB Cohen, EX Chen, EE Vokes, SJ Hotte, ...
Journal of Clinical Oncology 25 (25), 3978-3984, 2007
2202007
Epithelial–mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer
A Giordano, H Gao, S Anfossi, E Cohen, M Mego, BN Lee, S Tin, ...
Molecular cancer therapeutics 11 (11), 2526-2534, 2012
1892012
Expression of epithelial–mesenchymal transition‐inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy
M Mego, SA Mani, BN Lee, C Li, KW Evans, EN Cohen, H Gao, ...
International journal of cancer 130 (4), 808-816, 2012
1572012
Use of CAR-transduced natural killer cells in CD19-positive lymphoid tumors
E Liu, D Marin, P Banerjee, HA Macapinlac, P Thompson, R Basar, ...
New England Journal of Medicine 382 (6), 545-553, 2020
1422020
Detection of minimal residual disease in blood and bone marrow in early stage breast cancer
S Krishnamurthy, M Cristofanilli, B Singh, J Reuben, H Gao, EN Cohen, ...
Cancer 116 (14), 3330-3337, 2010
1312010
Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination
M Giuliano, A Giordano, S Jackson, U De Giorgi, M Mego, EN Cohen, ...
Breast cancer research 16 (5), 1-9, 2014
1122014
Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44+ CD24lo cancer stem …
JM Reuben, BN Lee, H Gao, EN Cohen, M Mego, A Giordano, X Wang, ...
European journal of cancer 47 (10), 1527-1536, 2011
1012011
Treatment with lenalidomide modulates T‐cell immunophenotype and cytokine production in patients with chronic lymphocytic leukemia
BN Lee, H Gao, EN Cohen, X Badoux, WG Wierda, Z Estrov, SH Faderl, ...
Cancer 117 (17), 3999-4008, 2011
882011
Inflammation mediated metastasis: immune induced epithelial-to-mesenchymal transition in inflammatory breast cancer cells
EN Cohen, H Gao, S Anfossi, M Mego, NG Reddy, B Debeb, A Giordano, ...
PloS one 10 (7), e0132710, 2015
792015
Synthetic tumor‐specific breakpoint peptide vaccine in patients with chronic myeloid leukemia and minimal residual disease: a phase 2 trial
N Jain, JM Reuben, H Kantarjian, C Li, H Gao, BN Lee, EN Cohen, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2009
662009
High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast …
S Anfossi, A Giordano, H Gao, EN Cohen, S Tin, Q Wu, RJ Garza, ...
PloS one 9 (1), e83113, 2014
652014
Prognostic value of EMT-circulating tumor cells in metastatic breast cancer patients undergoing high-dose chemotherapy with autologous hematopoietic stem cell transplantation
M Mego, H Gao, BN Lee, EN Cohen, S Tin, A Giordano, Q Wu, P Liu, ...
Journal of Cancer 3, 369, 2012
652012
Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells
BG Debeb, EN Cohen, K Boley, EM Freiter, L Li, FM Robertson, ...
Breast cancer research and treatment 134 (2), 495-510, 2012
632012
Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells
BG Debeb, X Zhang, S Krishnamurthy, H Gao, E Cohen, L Li, ...
Molecular cancer 9 (1), 1-12, 2010
592010
The role of thalidomide and placebo for the treatment of cancer-related anorexia-cachexia symptoms: results of a double-blind placebo-controlled randomized study
S Yennurajalingam, JS Willey, JL Palmer, J Allo, ED Fabbro, EN Cohen, ...
Journal of palliative medicine 15 (10), 1059-1064, 2012
532012
Immunotherapy of head and neck cancer: emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting
JE Bauman, E Cohen, RL Ferris, DJ Adelstein, DM Brizel, JA Ridge, ...
Cancer 123 (7), 1259-1271, 2017
472017
Inflammatory markers and development of symptom burden in patients with multiple myeloma during autologous stem cell transplantation
XS Wang, Q Shi, ND Shah, CJ Heijnen, EN Cohen, JM Reuben, ...
Clinical Cancer Research 20 (5), 1366-1374, 2014
472014
Modification of a hydrophobic layer by a point mutation in syntaxin 1A regulates the rate of synaptic vesicle fusion
RD Lagow, H Bao, EN Cohen, RW Daniels, A Zuzek, WH Williams, ...
PLoS Biol 5 (4), e72, 2007
462007
Circulating tumor cells (CTC) are associated with defects in adaptive immunity in patients with inflammatory breast cancer
M Mego, H Gao, EN Cohen, S Anfossi, A Giordano, T Sanda, TM Fouad, ...
Journal of Cancer 7 (9), 1095, 2016
382016
The system can't perform the operation now. Try again later.
Articles 1–20